| Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 218 | 2016 |
| Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models A Bahreini, Z Li, P Wang, KM Levine, N Tasdemir, L Cao, HM Weir, ... Breast Cancer Research 19, 1-10, 2017 | 147 | 2017 |
| Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response MJ Sikora, KL Cooper, A Bahreini, S Luthra, G Wang, UR Chandran, ... Cancer research 74 (5), 1463-1474, 2014 | 146 | 2014 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of oncology 29 (4), 872-880, 2018 | 106 | 2018 |
| The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility SA Bahreini, MR Jabalameli, M Saadatnia, H Zahednasab Journal of neuroimmunology 229 (1-2), 5-15, 2010 | 44 | 2010 |
| Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells Z Li, KM Levine, A Bahreini, P Wang, D Chu, BH Park, S Oesterreich, ... Endocrinology 159 (1), 285-296, 2018 | 42 | 2018 |
| Frequent ESR1 and CDK pathway copy-number alterations in metastatic breast cancer A Basudan, N Priedigkeit, RJ Hartmaier, ES Sokol, A Bahreini, RJ Watters, ... Molecular Cancer Research 17 (2), 457-468, 2019 | 40 | 2019 |
| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation Z Li, O McGinn, Y Wu, A Bahreini, NM Priedigkeit, K Ding, S Onkar, ... Nature Communications 13 (1), 2011, 2022 | 39 | 2022 |
| Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... Cancer research 82 (7), 1321-1339, 2022 | 36 | 2022 |
| Targeted mutation detection in breast cancer using MammaSeq™ NG Smith, R Gyanchandani, OS Shah, GT Gurda, PC Lucas, ... Breast Cancer Research 21, 1-11, 2019 | 31 | 2019 |
| Clinically observed estrogen receptor alpha mutations within the ligand-binding domain confer distinguishable phenotypes S Jia, MT Miedel, M Ngo, R Hessenius, N Chen, P Wang, A Bahreini, Z Li, ... Oncology 94 (3), 176-189, 2018 | 25 | 2018 |
| SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma EA Bossart, N Tasdemir, MJ Sikora, A Bahreini, KM Levine, J Chen, ... Breast cancer research and treatment 175, 327-337, 2019 | 18 | 2019 |
| Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma L Cao, A Basudan, MJ Sikora, A Bahreini, N Tasdemir, KM Levine, ... Cancer letters 461, 21-30, 2019 | 17 | 2019 |
| Controversial role of MMP-9 gene in MS disease H Zahednasab, M Saadatnia, MR Jabalameli, H Zarkesh-Esfahani, ... Journal of neuroimmunology 230 (1), 191, 2011 | 10 | 2011 |
| Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy TT Koopmann, Y Jamshidi, M Naghibi-Sistani, HM van der Klift, H Birjandi, ... European Journal of Human Genetics 31 (1), 97-104, 2023 | 9 | 2023 |
| Non-coding single nucleotide variants affecting estrogen receptor binding and activity A Bahreini, K Levine, L Santana-Santos, PV Benos, P Wang, C Andersen, ... Genome Medicine 8, 1-11, 2016 | 8 | 2016 |
| Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities … DG Calame, I Herman, R Maroofian, AE Marshall, KC Donis, JM Fatih, ... Annals of neurology 92 (2), 304-321, 2022 | 6 | 2022 |
| A recurrent homozygous missense DPM3 variant leads to muscle and brain disease S Nagy, T Lau, S Alavi, EG Karimiani, J Vallian, BG Ng, S Noroozi Asl, ... Clinical genetics 102 (6), 530-536, 2022 | 5 | 2022 |
| A novel carcinogenic PI3Kα mutation suggesting the role of helical domain in transmitting nSH2 regulatory signals to kinase domain S Ghalamkari, S Alavi, H Mianesaz, F Khosravian, A Bahreini, M Salehi Life Sciences 269, 118759, 2021 | 5 | 2021 |
| Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities E Cali, M Suri, M Scala, MP Ferla, S Alavi, EA Faqeih, EK Bijlsma, ... Genetics in Medicine 25 (1), 135-142, 2023 | 4 | 2023 |
